Published in J Acquir Immune Defic Syndr Hum Retrovirol on August 15, 1998
Addressing the "risk environment" for injection drug users: the mysterious case of the missing cop. Milbank Q (2004) 3.72
Prevention and treatment of hepatitis C in injection drug users. Hepatology (2002) 1.88
Overcoming barriers to prevention, care, and treatment of hepatitis C in illicit drug users. Clin Infect Dis (2005) 1.80
Sexual relationships, secondary syringe exchange, and gender differences in HIV risk among drug injectors. J Urban Health (2004) 1.25
Changes in injection risk behavior associated with participation in the Seattle needle-exchange program. J Urban Health (2000) 1.22
Epidemiology of HIV/AIDS, hepatitis B, hepatitis C, and tuberculosis among minority injection drug users. Public Health Rep (2002) 1.13
Secondary syringe exchange among injection drug users. J Urban Health (2003) 1.12
Syringe access, syringe sharing, and police encounters among people who inject drugs in New York City: a community-level perspective. Int J Drug Policy (2013) 1.00
Experiences with and attitudes toward death and dying among homeless persons. J Gen Intern Med (2007) 0.95
An inconvenient dataset: bias and inappropriate inference with the multilevel model. Qual Quant (2014) 0.95
Neighborhood differences in patterns of syringe access, use, and discard among injection drug users: implications for HIV outreach and prevention education. J Urban Health (2003) 0.94
The provision of non-needle/syringe drug injecting paraphernalia in the primary prevention of HCV among IDU: a systematic review. BMC Public Health (2010) 0.87
The syringe gap: an assessment of sterile syringe need and acquisition among syringe exchange program participants in New York City. Harm Reduct J (2009) 0.86
Overview of HIV among injection drug users in New York City: critical next steps to eliminate racial/ethnic disparities. Subst Use Misuse (2011) 0.84
Factors associated with uptake, adherence, and efficacy of hepatitis C treatment in people who inject drugs: a literature review. Patient Prefer Adherence (2013) 0.83
Characteristics and utilization patterns of needle-exchange attendees in Chicago: 1994-1998. J Urban Health (2000) 0.79
Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: risk-factor analysis. Lancet (2001) 5.28
Transmission from one child to another of human immunodeficiency virus type 1 with a zidovudine-resistance mutation. N Engl J Med (1993) 5.00
Predictors and prevention of nonfatal overdose among street-recruited injection heroin users in the San Francisco Bay Area, 1998-1999. Am J Public Health (2001) 3.43
High prevalence of abscesses and cellulitis among community-recruited injection drug users in San Francisco. Clin Infect Dis (2000) 2.71
Impact of law enforcement on syringe exchange programs: a look at Oakland and San Francisco. Med Anthropol (1997) 2.36
The effect of syringe exchange use on high-risk injection drug users: a cohort study. AIDS (2000) 2.20
Is it justifiable to withhold treatment for hepatitis C from illicit-drug users? N Engl J Med (2001) 2.12
Prevalence and duration of hepatitis C among injection drug users in San Francisco, Calif. Am J Public Health (2001) 2.02
Risk factors among IDUs who give injections to or receive injections from other drug users. Addiction (1999) 1.94
Risk factors for skin and soft-tissue abscesses among injection drug users: a case-control study. Clin Infect Dis (2001) 1.88
Sex- and drug-related risk among populations of younger and older injection drug users in adjacent neighborhoods in San Francisco. J Acquir Immune Defic Syndr (2000) 1.87
Sex trading and psychological distress among women recruited from the streets of Harlem. Am J Public Health (1997) 1.81
Frequency and thoroughness of STD/HIV risk assessment by physicians in a high-risk metropolitan area. Am J Public Health (1991) 1.71
Crack cocaine smoking and oral sores in three inner-city neighborhoods. J Acquir Immune Defic Syndr Hum Retrovirol (1996) 1.65
Tuberculosis in patients infected with human immunodeficiency virus: perspective on the past decade. Clin Infect Dis (1996) 1.56
Insemination of HIV-negative women with processed semen of HIV-positive partners. Lancet (1993) 1.50
Suicidal behavior and sexual/physical abuse among street youth. Child Abuse Negl (1998) 1.42
The high-risk sexual practices of crack-smoking sex workers recruited from the streets of three American cities. The Multicenter Crack Cocaine and HIV Infection Study Team. Sex Transm Dis (1998) 1.42
Individuals from North America, Australasia, and Africa are infected with four different genotypes of human herpesvirus 8. Virology (1999) 1.32
Crack cocaine smokers who turn to drug injection: characteristics, factors associated with injection, and implications for HIV transmission. The Multicenter Crack Cocaine and HIV Infection Study Team. Drug Alcohol Depend (1996) 1.31
Trends in HIV seroprevalence and risk among gay and bisexual men who inject drugs in San Francisco, 1988 to 2000. J Acquir Immune Defic Syndr (2001) 1.22
The inverse relationship between chronic HBV and HCV infections among injection drug users is associated with decades of age and drug use. J Viral Hepat (2008) 1.22
Risk of hepatitis B infection among young injection drug users in San Francisco: opportunities for intervention. West J Med (2000) 1.21
Hepatitis C virus-specific T-cell immune responses in seronegative injection drug users. J Viral Hepat (2008) 1.21
HIV seroprevalence in injection drug users. JAMA (1995) 1.19
Incentives and accessibility: a pilot study to promote adherence to TB prophylaxis in a high-risk community. J Urban Health (1999) 1.19
Prevention of peripheral venous catheter complications with an intravenous therapy team: a randomized controlled trial. Arch Intern Med (1998) 1.17
Unmet need for recommended preventive health services among clients of California syringe exchange programs: implications for quality improvement. Drug Alcohol Depend (2005) 1.16
Crack cocaine use and sexual activity in Miami, Florida. J Psychoactive Drugs (1993) 1.12
HIV infection among female injection-drug users recruited in community settings. Sex Transm Dis (1995) 1.05
Sex trading and psychological distress in a street-based sample of low-income urban men. J Psychoactive Drugs (2001) 1.03
Hepatitis C patients' self-reported adherence to treatment with pegylated interferon and ribavirin. Aliment Pharmacol Ther (2008) 1.02
Use of health care services by women who use crack cocaine. Women Health (1999) 0.95
Differences between men and women with HIV-related Pneumocystis carinii pneumonia: experience from 3,070 cases in New York City in 1987. J Acquir Immune Defic Syndr (1993) 0.92
Evaluation of infection control measures in preventing the nosocomial transmission of multidrug-resistant Mycobacterium tuberculosis in a New York City hospital. Infect Control Hosp Epidemiol (1995) 0.91
Urban rape survivors: characteristics and prevalence of human immunodeficiency virus and other sexually transmitted infections. Multicenter Crack Cocaine and HIV Infection Study Team. Obstet Gynecol (1995) 0.90
Genetic variation in CLDN1 and susceptibility to hepatitis C virus infection. J Viral Hepat (2009) 0.88
Interferon-alpha plus zidovudine in HIV infection. Lancet (1989) 0.88
Variations in medical care for HIV-related Pneumocystis carinii pneumonia: a comparison of process and outcome at two hospitals. Chest (1997) 0.79
Harm reduction and needle exchange programmes. Lancet (1998) 0.77
Health care use by human immunodeficiency virus-infected students at a California student health service. West J Med (1992) 0.75
Cost-effectiveness of hepatitis B virus immunization. JAMA (1996) 0.75
Tuberculin skin testing of hospital employees during an outbreak of multidrug-resistant tuberculosis in human immunodeficiency virus (HIV)-infected patients. Infect Control Hosp Epidemiol (1992) 0.75
Change of HAART. Highly active antiretroviral therapy. Lancet (1999) 0.75
Clusters of multidrug-resistant tuberculosis. Ann Intern Med (1993) 0.75